Immunoglobulin G Fc Receptor FcγRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma

PURPOSE: Rituximab has been given after autologous hematopoietic cell transplantation for recurrent or refractory B-cell lymphoma with the goal of eradicating minimal residual disease. Our previous report showed that administration of two courses of rituximab after transplantation is feasible, with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Weng, Wen-Kai, Negrin, Robert S., Lavori, Philip, Horning, Sandra J.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2010
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815716/
https://ncbi.nlm.nih.gov/pubmed/19933905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.0274
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki